Enforcement record
Criminal Accusation disclosure naming ノバルティス ファーマ株式会社
This page records one action from a Japanese government disclosure, including the published name, governing law, authority, action details, and official source.
Action type
Criminal Accusation
Law
Pharmaceutical Affairs Act
Authority
Ministry of Health, Labour and Welfare
Action date
9 January 2014
RegBase evidence report
Japanese public-record enforcement check
Saveable record of the published action, regulator source, source status, and review notes for internal compliance files.
- Report ID
- RB-EN-ENFORCEMENT-OTHER-NOBARUTEISU-202608131757
- Generated at
- 14 August 2026 at 02:57
- Record URL
- https://regbase.jp/en/enforcement/other-nobaruteisuhuama-20140109
1. Review Summary
| Disclosure name | ノバルティス ファーマ株式会社 | Corporate Number | Not stated in the disclosure |
|---|---|---|---|
| Enforcement record | 1 record | Other confirmed records for this company | Outside this report's scope |
| Action date | 9 January 2014 | Authority | Ministry of Health, Labour and Welfare |
| Law | Pharmaceutical Affairs Act | Action type | Criminal Accusation |
| Source status | Preserved public-source archive recorded | ||
This report summarizes public Japanese government disclosure data held by RegBase. It is not a credit score, sanctions conclusion, legal opinion, or adverse-media determination. Confirm important decisions against the linked official Japanese source.
2. Published Information
| Published name | ノバルティス ファーマ株式会社 |
|---|
3. Enforcement Record
| Target name in disclosure | ノバルティス ファーマ株式会社 |
|---|---|
| Authority | Ministry of Health, Labour and Welfare (厚生労働省) |
| Law / action type | Pharmaceutical Affairs Act / Criminal Accusation |
| Action / announcement date | Action: 9 January 2014 / Announcement: 19 March 2026 |
| English summary | Novartis Pharma K.K. used materials that described the results of clinical studies, the 'JIKEI HEART Study' conducted at Tokyo Jikei Medical University and the 'KYOTO HEART Study' conducted at Kyoto Prefectural University of Medicine, to advertise the efficacy or effects of the drug Diovan tablets. These advertisements were made using the results of these clinical studies. |
| Original Japanese text | ノバルティス ファーマ株式会社は、平成23年から平成24年にかけて、ディオバン錠に係る東京慈恵会医科大学において実施された臨床研究である「JIKEI HEART Study」及び京都府立医科大学において実施された臨床研究である「KYOTO HEART Study」の結果を記載した資材を用いて、同医薬品の効能又は効果に関して広告を行った。 |
| Official source | https://www.mhlw.go.jp/stf/houdou/0000034241.html |
| Source archive | https://kiroku.today/a/db56d347f1he9l4c |
| Extraction / evidence timestamps | Extracted: 25 April 2026 at 08:31 / Evidence checked: 25 April 2026 at 08:31 / Archive captured: 12 July 2026 at 15:14 |
4. Business Location and Permit Details
No additional structured business-location or permit fields are recorded for this disclosure.
5. Other Confirmed Records for This Company
This report covers the single government disclosure shown on this page.
Reviewer Notes
| Reviewer | Team / company | ||
|---|---|---|---|
| Review purpose | |||
| Additional notes | |||
- □ Official source URL or archived source was checked.
- □ Corporate Number, address, or other identifiers were reviewed to avoid confusing similarly named entities.
- □ This document is understood as a public-record evidence file, not a credit decision or legal opinion.
Current page: Enforcement record
This screen focuses on one disclosed action: the published name, governing law, authority, facts, source status, and review evidence.
Free report
Save the disclosure record naming ノバルティス ファーマ株式会社
Includes the published name, regulator, governing law, source links, archive status, and reviewer note fields for internal due-diligence files.
Preserved evidence by Kiroku
Review the preserved source for ノバルティス ファーマ株式会社
Open the preserved public source with its capture time, original artifact, available verification data, and downloadable evidence pack.
For developers: JSON integration details
You do not need this for normal browsing. Use it only when integrating this enforcement record into an internal tool or AI workflow.
Action summary
- Company
- ノバルティス ファーマ株式会社Japanese onlyOriginal: ノバルティス ファーマ株式会社
- Governing law
- Pharmaceutical Affairs Act薬事法
- Action type
- Criminal Accusation告発
- Action date
- 9 January 2014
- Issuing authority
- Ministry of Health, Labour and Welfare厚生労働省
- Industry context
- 医薬品広告
Violation
Novartis Pharma K.K. used materials that described the results of clinical studies, the 'JIKEI HEART Study' conducted at Tokyo Jikei Medical University and the 'KYOTO HEART Study' conducted at Kyoto Prefectural University of Medicine, to advertise the efficacy or effects of the drug Diovan tablets. These advertisements were made using the results of these clinical studies.
Show original Japanese text
ノバルティス ファーマ株式会社は、平成23年から平成24年にかけて、ディオバン錠に係る東京慈恵会医科大学において実施された臨床研究である「JIKEI HEART Study」及び京都府立医科大学において実施された臨床研究である「KYOTO HEART Study」の結果を記載した資材を用いて、同医薬品の効能又は効果に関して広告を行った。
Compliance context
HighThe authority announced a criminal accusation or referral based on the disclosed facts.
Japanese regulatory disclosure under Pharmaceutical Affairs Act.
Escalate for legal review and check whether later public records changed the status of the matter.
This context is an operational aid for review workflows, not a credit opinion or legal conclusion.
Evidence pack
- Extracted at
- 2026-04-24T23:31:43.527+00:00
- Evidence checked
- 2026-04-24T23:31:43.527+00:00
- Archive captured
- 2026-07-12T06:14:01.017315+00:00
Show audit JSON
{
"record": {
"id": "c6dd049c-afab-4bc2-9b85-802c589b86f2",
"url": "https://regbase.jp/en/enforcement/other-nobaruteisuhuama-20140109",
"company_name_original": "ノバルティス ファーマ株式会社",
"company_name_registry": null,
"corporate_number": null,
"law": {
"ja": "薬事法",
"en": "Pharmaceutical Affairs Act"
},
"action_type": {
"ja": "告発",
"en": "Criminal Accusation"
},
"authority": {
"ja": "厚生労働省",
"en": "Ministry of Health, Labour and Welfare"
}
},
"entity_match": {
"status": "unresolved",
"confidence": 85,
"method": "nta_strict_name_nationally_unique",
"method_label": "nta_strict_name_nationally_unique",
"notes": "NTA full-download lookup found a nationally unique exact registered-name candidate (ノバルティスファーマ株式会社). No Corporate Number was present in the disclosure, so this remains a likely match."
},
"review": {
"status": "unreviewed",
"label": "Machine extracted"
},
"compliance_context": {
"severity": "High",
"actionMeaning": "The authority announced a criminal accusation or referral based on the disclosed facts.",
"practicalNote": "Escalate for legal review and check whether later public records changed the status of the matter.",
"lawContext": "Japanese regulatory disclosure under Pharmaceutical Affairs Act."
},
"evidence": {
"recordUrl": "https://regbase.jp/en/enforcement/other-nobaruteisuhuama-20140109",
"officialSourceUrl": "https://www.mhlw.go.jp/stf/houdou/0000034241.html",
"officialDocumentUrl": null,
"archiveUrl": "https://kiroku.today/a/db56d347f1he9l4c",
"archivedSourceUrl": "https://www.mhlw.go.jp/stf/houdou/0000034241.html",
"archiveCapturedAt": "2026-07-12T06:14:01.017315+00:00",
"extractedAt": "2026-04-24T23:31:43.527+00:00",
"translatedAt": "2026-05-01T06:48:30.886+00:00",
"evidenceCheckedAt": "2026-04-24T23:31:43.527+00:00",
"generatedAt": "2026-08-13T17:57:43.307Z"
},
"limitations": [
"RegBase aggregates public Japanese government disclosures and does not provide a credit opinion.",
"English summaries are provided for reference. The original Japanese source is authoritative.",
"Possible or unresolved entity matches should be manually verified before use in a decision."
]
}The original Japanese disclosure is the authoritative record. Use possible or unresolved matches only as leads for manual review.
Language
日本語版を見る (Japanese)About this recordAggregated and translated from public Japanese government disclosures. The English text is for reference only — authoritative content is the linked Japanese source.